Gufic Biosciences Ltd. benchmarking: Perfomance to industry peers

Financial

	Gufic Biosciences	Unichem Lab	Panacea Biotec
Operational Metrics
Pharmaceuticals
R&D as a % of Total Sales	1.28 %	5.35 %	9.86 %
Financials
5 yr Average ROE	16.89 %	-0.79 %	36.5 %
5yr average Equity Multiplier	2.16	1.32	0.36
5yr Average Asset Turnover Ratio	0.75	0.47	0.41
5yr Avg Net Profit Margin	10.24 %	-1.68 %	26.1 %
Price to Book	5.58	1.32	3.04
P/E	54.27	24.78	221.1
5yr Avg Cash Conversion Cycle	-15.25 Days	88.84 Days	-170.26 Days
Inventory Days	71.73 Days	151.32 Days	120.03 Days
Days Receivable	106.89 Days	122.86 Days	42.2 Days
Days Payable	179.29 Days	205.05 Days	325.14 Days
5yr Average Interest Coverage Ratio	8.9	2.41	2.7
5yr Avg ROCE	17.89 %	1.04 %	-2.79 %
5yr Avg Operating Profit Margin	18.12 %	5.43 %	-3.85 %
5 yr average Debt to Equity	0.67	0.11	-0.69
5yr CAGR Net Profit	-2.66 %	32.0 %	-43.68 %
5yr Average Return on Assets	7.7 %	-0.65 %	9.32 %
Shareholdings
Promoter Holding	72.5 %	70.22 %	72.48 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-2.5 %	19.29 %	-1.11 %
Change in Mutual Fund Holding (3 Yrs)	2.45 %	1.88 %	0.0

	Gufic Biosciences	Unichem Lab	Panacea Biotec
Product Wise Break-Up	Product Wise Break-Up Domestic Pharmaceuticals 50.0 CMO 30.0 International 15.0 Active Pharmaceutical Ingredient (API) 5.0 Muscle Relaxants 0 Cardiovascular 0 Proton pump inhibitors 0 Anti-fungals 0 Anti-bacterials 0 Bulk Drugs and chemicals 0 Formulations 0 Research and Development 0 Vaccines 0	Product Wise Break-Up Active Pharmaceutical Ingredient (API) 0 Cardiovascular 0 Anti-fungals 0 Formulations 92.3 Research and Development 0 Anti-bacterials 0 CMO 0 International 0 Domestic Pharmaceuticals 0 Proton pump inhibitors 0 Vaccines 0 Muscle Relaxants 0 Bulk Chemicals 7.7	Product Wise Break-Up Active Pharmaceutical Ingredient (API) 0 Cardiovascular 0 Anti-fungals 0 Formulations 32.66 Research and Development 0 Anti-bacterials 0 CMO 0 International 0 Domestic Pharmaceuticals 0 Proton pump inhibitors 0 Vaccines 67.34 Muscle Relaxants 0 Bulk Drugs and chemicals 0
Location Wise Break-Up	Location Wise Break-Up India 79.83 Europe 7.54 Asia Pacific 6.04 Africa 2.95 South America 2.37 North America 1.19 Australia 0.08 Rest of the World 0 USA 0	Location Wise Break-Up Rest of the World 0 Europe 0 Australia 0 USA 64.2 Africa 0 South America 0 Asia Pacific 0 India 1.97 North America 0 Others 33.83	Location Wise Break-Up Rest of the World 86.09 Europe 0 Australia 0 USA 0 Africa 0 South America 0 Asia Pacific 0 India 13.91 North America 0